TechNavio Announces the Publication of its Research Report – Global Kinase Inhibitors Market 2011-2015

Renewable energy

TechNavio today launched its report, Global Kinase Inhibitors Market 2011-2015, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Drug development and manufacture is a complex and time-consuming process, and it requires huge financial investment. Due to higher overheads and labor costs, vendors prefer to outsource their production to different RandD houses. This strategy helps vendors reduce the manufacturing costs, achieve optimum quality, and avoid production delays. Some of the vendors are outsourcing different parts of research work, such as product characterization testing and toxicology testing, to different contract research organizations. Similarly, some vendors are increasingly outsourcing part of their enzyme inhibitor drug manufacturing or the entire manufacturing process to various contract manufacturing organizations. Thus, the increase in the outsourcing of drug manufacture is one of the trends witnessed by the Global Kinase Inhibitor market.”
According to the report, globally, there has been an increase in the incidence of various diseases such as cardiovascular diseases (CVD), cancer, hypertension, inflammatory, respiratory diseases, infections, and other diseases. This is due to a variety of factors, such as unhealthy dietary habits, lack of physical activity, excessive consumption of alcohol, and smoking. Furthermore, the rapidly expanding elderly population is increasing the chance of people being prone to all these diseases. Thus, the increasing prevalence of diseases increases the demand for various drugs used in their treatment. This, in turn, increases the demand for enzyme inhibitors, thereby driving the growth of the Global Kinase Inhibitors market.
Further, the report reveals that the patent expiry of top-selling drugs is a challenge for the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-kinase-inhibitors-market-2011-2015
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio